Endogenous Endophthalmitis in the Inpatient Setting

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by Stanford University.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Theodore Leng, Stanford University
ClinicalTrials.gov Identifier:
NCT01323868
First received: March 24, 2011
Last updated: March 22, 2012
Last verified: March 2012

March 24, 2011
March 22, 2012
July 2010
June 2013   (final data collection date for primary outcome measure)
Positive intraocular infection [ Time Frame: 1 day ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01323868 on ClinicalTrials.gov Archive Site
Visual acuity [ Time Frame: 2 wk ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Endogenous Endophthalmitis in the Inpatient Setting
Endogenous Endophthalmitis Rates, Clinical Course, and Outcomes

The purpose of this study is to determine the rate of endogenous endophthalmitis in patients admitted to Stanford Hospital with a systemic infection and positive blood cultures, as this may improve the clinical care of this population of patients.

Some patients admitted to the hospital have blood-borne infections. Occasionally, these blood infections can end up inside the eye and cause an infection inside the eye (called endogenous endophthalmitis).

Prior to modern and rapid treatment of systemic infections, the rate of endogenous endophthalmitis was reported to be 37% in 1982. By 1997, the rate was reported to be 2.8%. This study aims to determine the rate of endogenous endophthalmitis at Stanford Hospital in the modern medical era in that our rates may be different as those reported in the literature. This potential difference may be a reflection of treatment protocols and antibiotics currently in use at Stanford Hospital.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Inpatients at Stanford Hospital with positive blood cultures who receive an Ophthalmology consultation and eye examination.

Endophthalmitis
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
390
June 2013
June 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:All patients admitted to Stanford Hospital that have a systemic blood-borne infection and on which an Ophthalmology consult to rule out endogenous endophthalmitis is performed will be included in the study.

Exclusion Criteria:None

Both
Not Provided
No
Contact: Theodore Leng, MD (650) 723-6995
United States
 
NCT01323868
SU-03232011-7621, IRB-18785
Not Provided
Theodore Leng, Stanford University
Stanford University
Not Provided
Principal Investigator: Theodore Leng Stanford University
Stanford University
March 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP